Yantai – September 09, 2026 -- CelluPro has become the first Chinese cell culture media supplier to receive EXCiPACTTM GMP Certification for Pharmaceutical Auxiliary Materials (PAMs), a credential aimed at strengthening its position in global biomanufacturing supply chains.
EXCiPACT certification sets an internationally recognized GMP benchmark for cell culture media suppliers
The EXCiPACTTM scheme establishes GMP requirements for materials used in biopharmaceutical manufacturing, providing an independent framework to assess quality management, manufacturing controls, traceability, and supply chain practices. For CelluPro, the certification adds to an existing quality portfolio that includes ISO 9001, ISO 13485, ISO 14001, ISO 45001, and ISO 22301 certifications covering quality, environmental, occupational health and safety, and business continuity management.
CelluPro has backed three commercial manufacturing projects for global multinational partners
Drawing on more than a decade of experience in cell culture media formulation and upstream bioprocessing, CelluPro's manufacturing platform spans process development through clinical and commercial production. Applications include CHO-based recombinant protein and antibody production, HEK293-based protein and viral vector production, and cell and gene therapy. The company has supported three commercial manufacturing projects for global MNC partners and has experience backing commercialized biopharmaceutical products through both FDA BLA and EMA submissions.
Company expands international supply capacity as biopharma pipelines shift toward commercial-scale manufacturing
As biopharmaceutical development pipelines move from early research toward clinical and commercial manufacturing, demand is rising for cell culture media that can meet quality, scalability, traceability, and regulatory requirements across later-stage production. CelluPro is expanding its manufacturing and international supply capabilities to offer biopharmaceutical manufacturers worldwide an additional GMP-grade media source and greater flexibility in global sourcing.